Immune treatment using exosome therapy for severe COVID-19
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether immune-supporting treatment made from exosomes can help people with critically severe COVID-19 and lung damage. If you qualify, you may receive this therapy as part of the study to see if it improves outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be hospitalized with critically ill COVID-19.
- Your COVID-19 must be at least “severe” (WHO severity level 4 or higher).
- You must have lung dysfunction consistent with ARDS (a serious lung condition from COVID-19).
- You must weigh more than 50 kg.
- You (or your legal representative) must be able to give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether donated-from-your-own-fat stem cells can improve outcomes for people who are high risk for getting COVID-19, but who have never had COVID-19 and test negative right now. It may help your immune system and reduce complications if you become infected during the study.
This trial tests whether donated “recovered patient” plasma (antibodies from people who had COVID-19) can improve outcomes for people hospitalized with COVID-19. It focuses on patients early in their illness who need a small amount of oxygen.
This study looks at how the body's immune system reacted to COVID-19 in people who had either severe or mild cases. The goal is to learn more about a specific part of the immune response (called IFN-I) to better understand the disease.
This trial tests a new medicine made from stem cells to see if it can help people with COVID-19 symptoms. It's for people who are overweight or moderately obese, have had symptoms for a few days, and have tested positive for COVID-19.
This study collects immune cells from people who recovered from COVID-19 and may use them to boost protection against SARS-CoV-2. It’s for hospitalized patients who already show a certain level of COVID-19 fighting immune response.
This trial tests donated (allogeneic) fat-derived stem cells to see if they improve outcomes in adults with severe or critical COVID-19. It may help calm severe lung/immune problems, but whether it works and is safe will be studied in this Phase 2 study.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.